NCT03566316View on ClinicalTrials.gov

Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

PHASE3CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

November 24, 2015

Primary Completion Date

June 16, 2017

Study Completion Date

June 16, 2017

Conditions
Hypertension With Hyperlipidemia
Interventions
DRUG

Telmisartan/Amlodipine

DRUG

Rosuvastatin

DRUG

Telmisartan

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03566316 - Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter